Gideon Pharma Testosterone Enanthate Lab Test Results
June 7, 2024
Summary The product Testosterone Enanthate 250 mg/mL, manufactured by Gideon Pharma Limited, underwent independent testing to verify its authenticity and
Vendor Funded Testing
Gideon Pharma Testosterone Propionate Lab Test Results
June 7, 2024Summary The product Testosterone Propionate 100 mg/mL, manufactured by Gideon Pharma Limited, underwent independent testing to verify its authenticity and
Gideon Pharma Testosterone Cypionate Lab Test Results
June 7, 2024Summary The product Testosterone Cypionate 250 mg/mL, manufactured by Gideon Pharma Limited, underwent independent testing to verify its authenticity and
Axle Labs Halotestin Lab Test Results
June 3, 2024Summary The product Halotestin 10 mg caps, manufactured by Axle Labs, underwent independent testing to verify its authenticity and potency.
Axle Labs Trestolone Acetate (MENT) Lab Test Results
June 3, 2024Summary The product Trestolone Acetate (MENT) 100 mg/ml, manufactured by Axle Labs, underwent independent testing to verify its authenticity and
Axle Labs Testosterone Propionate Lab Test Results
June 3, 2024Summary The product Testosterone Propionate 200 mg/ml, manufactured by Axle Labs, underwent independent testing to verify its authenticity and potency.
Unique Pharma MAST E Lab Test Results
June 2, 2024Summary The product MAST E Drostanolone Enanthate 200 mg/ml, manufactured by Unique Pharma, was independently tested to verify its authenticity
Unique Pharma DHB 50 Lab Test Results
June 2, 2024Summary The product DHB 50 Dihydroboldenone 50 mg/ml, manufactured by Unique Pharma, was independently tested to verify its authenticity and
Unique Pharma Arimidex Lab Test Results
June 2, 2024Summary The product ARIMIDEX 1 mg tablets, manufactured by Unique Pharma, underwent independent testing for quality verification. The sample, identified
Unique Pharma TEST E 250 Lab Test Results
June 2, 2024Summary The product TEST E 250 Testosterone Enanthate, manufactured by Unique Pharma, batch number UN55332 exp 04/2027, underwent qualitative and
